Skip to content
WeighLab

Gala Health vs Mochi Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Gala Health

Affiliate partner

Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.

Semaglutide / month
From $129/moCompounded (plan length not stated); brand Ozempic $1,299/mo
Tirzepatide / month
$179/moYearly subscription; $199/mo on a 3-month plan
Index 71/100 · Grade CChecked October 2026

Mochi Health

Provider comparison

Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.

Semaglutide / month
From $139/moIncludes $60 medication + $79/mo required membership; dose and pharmacy vary
Tirzepatide / month
From $169/moIncludes $90 medication + $79/mo required membership; dose and pharmacy vary
Index 73/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Mochi Health has the higher Cost-Efficiency Index: 73/100 versus 71/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Gala Health
50 states claimed, no list published
Mochi Health
All 50 states (per FAQ; product restrictions vary)

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Gala Health

Mochi Health

Semaglutide / month
Gala Health: From $129/moCompounded (plan length not stated); brand Ozempic $1,299/mo
Mochi Health: From $139/moIncludes $60 medication + $79/mo required membership; dose and pharmacy vary
Tirzepatide / month
Gala Health: $179/moYearly subscription; $199/mo on a 3-month plan
Mochi Health: From $169/moIncludes $90 medication + $79/mo required membership; dose and pharmacy vary
Semaglutide / year (modeled)
Gala Health: —
Mochi Health: $1,668
Tirzepatide / year (modeled)
Gala Health: $2,148
Mochi Health: $2,028
State availability
Gala Health: 50 states claimed, no list published
Mochi Health: All 50 states (per FAQ; product restrictions vary)
Oral / sublingual option listed
Gala Health: Not listed
Mochi Health: Yes
Brand-name access listed
Gala Health: Yes
Mochi Health: Yes
Provider facts checked
Gala Health: October 2026
Mochi Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Gala Health

Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.

Reasons to consider it

  • $179/mo on a yearly subscription, with every dose included, so the price does not climb as you titrate — dose escalation is where most flat-looking programs quietly get expensive
  • The price list is public and un-gated: the compounded tier and the brand tier are both printed before any quiz, intake or email capture
  • Both compounded molecules — semaglutide and tirzepatide — prescribable on one account

What to weigh up

  • No month-to-month price exists anywhere on the site. "FROM $179/month" sits directly above "All doses included. Yearly subscription.", and the cheapest alternative the FAQ names is "$199 per month (with a 3-month plan)" — three months is the shortest published commitment there is
  • $179/mo is $2,148 committed for the year, and that total is printed nowhere, which makes it hard to compare with a price you can cancel next month
  • Compounded semaglutide is advertised from $129 a month, but the plan length behind that figure isn't shown before checkout

Mochi Health

Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.

Reasons to consider it

  • Public starting totals include the required $79 monthly membership
  • Offers live provider visits, dietitian access and care-team messaging
  • FAQ says services are available throughout the United States

What to weigh up

  • Starting totals rise with dose and the selected pharmacy
  • Medication and diagnostic services are billed separately from membership
  • The homepage and weight-loss page show different first-month membership promotions; check checkout

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Gala HealthMochi Health
Normalized Cost/Month
Gala Health:
74/100
Mochi Health:
61/100
Price Transparency
Gala Health:
62/100
Mochi Health:
64/100
Nationwide Access
Gala Health:
76/100
Mochi Health:
86/100
Formulation Options
Gala Health:
82/100
Mochi Health:
95/100
Clinical Oversight
Gala Health:
80/100
Mochi Health:
79/100
Contract Flexibility
Gala Health:
50/100
Mochi Health:
63/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.